Discover how CRISPR-engineered human organoids are revolutionizing pancreatic cancer research by modeling early tumor development.
Discover how pancreatic cancer rewires its metabolism through HDAC1 deletion and fatty acid oxidation, revealing new therapeutic opportunities.
Discover how targeting DUSP1 and DUSP6 proteins offers new hope in pancreatic cancer treatment by activating cell death pathways and disrupting cancer metabolism.